STOREBRAND ASSET MANAGEMENT AS
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 1685676
LYSAKER, Q8
Position in VRTX
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$45,800,268
-$3,875,747 QoQ
Shares Held
102,567
-6.4% QoQ
Ownership
0.040%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026STOREBRAND ASSET MANAGEMENT AS holds $182,532,224 across 11 Biotechnology names. VRTX ranks #1 (25.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
102,567 | $45,800,268 | |
| 2 | RPRX |
Royalty Pharma plc
|
776,642 | $37,255,516 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
35,939 | $27,767,908 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
64,595 | $21,372,547 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
109,134 | $20,631,782 | |
| 6 | INSM |
INSMED Inc
|
90,826 | $14,851,867 | |
| 7 | INCY |
Incyte Corp
|
80,755 | $7,600,660 | |
| 8 | RVMD |
Revolution Medicines, Inc.
|
53,365 | $5,189,746 |
All Filings in VRTX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $45,800,268 | 102,567 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $49,676,015 | 109,573 | Shares | Sole | 2026-05-20 | |
| 2025-09-30 | $43,811,983 | 111,868 | Shares | Sole | 2026-06-03 | |
| 2025-06-30 | $48,207,591 | 108,283 | Shares | Sole | 2026-06-03 | |
| 2025-03-31 | $49,024,998 | 101,120 | Shares | Sole | 2026-06-03 | |
| 2024-12-31 | $54,385,037 | 135,051 | Shares | Sole | 2026-06-17 | |
| 2024-09-30 | $65,560,932 | 140,967 | Shares | Sole | 2026-06-17 | |
| 2024-06-30 | $72,783,310 | 155,281 | Shares | Sole | 2026-06-17 | |
| 2024-03-31 | $63,950,095 | 152,987 | Shares | Sole | 2026-06-17 | |
| 2023-12-31 | $64,345,991 | 158,141 | Shares | Sole | 2026-06-18 | |
| 2023-09-30 | $52,936,807 | 152,231 | Shares | Sole | 2026-06-18 | |
| 2023-06-30 | $52,108,369 | 148,073 | Shares | Sole | 2026-06-18 | |
| 2023-03-31 | $52,987,842 | 168,178 | Shares | Sole | 2026-06-18 | |
| 2022-12-31 | $52,379,782 | 181,383 | Shares | Sole | 2026-06-18 | |
| 2022-09-30 | $48,546,303 | 167,667 | Shares | Sole | 2026-06-18 | |
| 2022-06-30 | $39,077,791 | 138,677 | Shares | Sole | 2026-06-18 | |
| 2022-03-31 | $33,856,942 | 129,735 | Shares | Sole | 2026-06-18 | |
| 2021-12-31 | $19,593,590 | 89,224 | Shares | Sole | 2026-06-18 | |
| 2021-09-30 | $17,024,539 | 93,856 | Shares | Sole | 2026-06-18 | |
| 2021-06-30 | $20,385,801 | 101,105 | Shares | Sole | 2026-06-18 | |
| 2021-03-31 | $22,103,800 | 102,861 | Shares | Sole | 2026-06-18 | |
| 2020-12-31 | $29,850,214 | 126,302 | Shares | Sole | 2026-06-18 | |
| 2020-09-30 | $38,139,250 | 140,156 | Shares | Sole | 2026-06-18 | |
| 2020-06-30 | $37,289,738 | 128,448 | Shares | Sole | 2026-06-18 | |
| 2020-03-31 | $25,560,351 | 107,419 | Shares | Sole | 2026-06-18 | |
| No filing history on record for this holder in this stock. | ||||||